DSCM
ORGO icon

Divisadero Street Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Divisadero Street Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100,000
Closed -$284K – 78
2024
Q1 		$284K Buy
+100,000
New +$340K 0.07% 53

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Divisadero Street Capital Management's ORGO Position: Q2 2024 in Review

Divisadero Street Capital Management sold out of Organogenesis Holdings (ORGO) in Q2 2024, closing a stake of 100,000 shares — an estimated $284K sold.

Divisadero Street Capital Management first reported a position in ORGO in Q1 2024 and held it in 1 quarter. The position peaked at $284K in Q1 2024. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2024.

  • Divisadero Street Capital Management reported no remaining Organogenesis Holdings position as of Q2 2024 after selling out during the quarter.
  • Divisadero Street Capital Management sold 100,000 Organogenesis Holdings shares in Q2 2024, an estimated $284K.
  • Divisadero Street Capital Management first reported a position in Organogenesis Holdings in Q1 2024 and held it in 1 quarter.
  • Divisadero Street Capital Management's Organogenesis Holdings position peaked at $284K in Q1 2024.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2024.

Based on Divisadero Street Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.